Cite
HARVARD Citation
Chataway, J. et al. (2020). Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial. Lancet neurology. 19 (3), pp. 214-225. [Online].